Q97724284

Summary

Q97724284 is an individual motion^[1].

Key Facts

• Q97724284 authored Margareta Gunsdotter^[2].
• Q97724284's instance of is recorded as individual motion^[3].
• Q97724284's part of the series is recorded as motions of 2017-2018 legislative session of the Riksdag^[4].
• Q97724284's language of work or name is recorded as Swedish^[5].
• Q97724284 was published on +2017-10-03T00:00:00Z^[6].
• Q97724284's main subject is medication^[7].
• Q97724284's main subject is Swedish Medical Products Agency^[8].
• Q97724284's work available at URL is recorded as http://data.riksdagen.se/dokument/H5021296^[9].
• Q97724284's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H5021296^[10].
• Q97724284's applies to jurisdiction is recorded as Sweden^[11].
• Q97724284's legal citation of this text is recorded as Mot. 2017/18:1296^[12].
• Q97724284's title is recorded as Läkemedelsverkets biverkningsregister^[13].
• Q97724284's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97724284's copyright status is recorded as public domain^[15].
• Q97724284's legislative committee is recorded as Committee on Health and Welfare^[16].

Body

Definition and Type

Q97724284's instance of is recorded as individual motion^[3].